Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Nakashima

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|December 3, 2014
Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusionHaruhiko Nakamura, Tomoki Nakashima, Mikihito Hayashi, et al.
Inflammation and Regeneration|June 3, 2024
Emilin2 marks the target region for mesenchymal cell accumulation in bone regenerationYifan Qing, Takehito Ono, Yukihiro Kohara, et al.
Biochemical and Biophysical Research Communications|September 9, 2017
Targeted deletion of RANKL in M cell inducer cells by the Col6a1-Cre driverKazuki Nagashima, Shinichiro Sawa, Takeshi Nitta, et al.
Nature Immunology|April 25, 2017
Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiotaKazuki Nagashima, Shinichiro Sawa, Takeshi Nitta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Development of cyclic peptides with potent in vivo osteogenic activity through RaPID-based affinity maturationNasir K Bashiruddin, Mikihito Hayashi, Masanobu Nagano, et al.
Annals of the Rheumatic Diseases|May 31, 2015
RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammationLynett Danks, Noriko Komatsu, Matteo M Guerrini, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Blimp1-mediated repression of negative regulators is required for osteoclast differentiationKeizo Nishikawa, Tomoki Nakashima, Mikihito Hayashi, et al.
Modern Rheumatology|February 6, 2007
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritisAyako Suematsu, Yasuhito Tajiri, Tomoki Nakashima, et al.
Immunity|December 19, 2015
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous SystemMatteo M Guerrini, Kazuo Okamoto, Noriko Komatsu, et al.
Nature Medicine|March 8, 2005
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesisTeiji Wada, Tomoki Nakashima, Antonio J Oliveira-dos-Santos, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|December 3, 2014
Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusionHaruhiko Nakamura, Tomoki Nakashima, Mikihito Hayashi, et al.
Inflammation and Regeneration|June 3, 2024
Emilin2 marks the target region for mesenchymal cell accumulation in bone regenerationYifan Qing, Takehito Ono, Yukihiro Kohara, et al.
Biochemical and Biophysical Research Communications|September 9, 2017
Targeted deletion of RANKL in M cell inducer cells by the Col6a1-Cre driverKazuki Nagashima, Shinichiro Sawa, Takeshi Nitta, et al.
Nature Immunology|April 25, 2017
Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiotaKazuki Nagashima, Shinichiro Sawa, Takeshi Nitta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Development of cyclic peptides with potent in vivo osteogenic activity through RaPID-based affinity maturationNasir K Bashiruddin, Mikihito Hayashi, Masanobu Nagano, et al.
Annals of the Rheumatic Diseases|May 31, 2015
RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammationLynett Danks, Noriko Komatsu, Matteo M Guerrini, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Blimp1-mediated repression of negative regulators is required for osteoclast differentiationKeizo Nishikawa, Tomoki Nakashima, Mikihito Hayashi, et al.
Modern Rheumatology|February 6, 2007
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritisAyako Suematsu, Yasuhito Tajiri, Tomoki Nakashima, et al.
Immunity|December 19, 2015
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous SystemMatteo M Guerrini, Kazuo Okamoto, Noriko Komatsu, et al.
Nature Medicine|March 8, 2005
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesisTeiji Wada, Tomoki Nakashima, Antonio J Oliveira-dos-Santos, et al.
Pageof 9